Health Insurance Innovations (NASDAQ:HIIQ) updated its fourth quarter 2019
IntraDay earnings guidance on Monday morning. The company provided earnings per share guidance of 2.30-2.55 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.37. The company issued revenue guidance of $159-164 million, compared to the consensus revenue estimate of $172.37 million.Health Insurance Innovations also updated its FY 2019
IntraDay guidance to 4.10-4.35 EPS.
Shares of HIIQ stock opened at $20.20 on Thursday. Health Insurance Innovations has a 1 year low of $15.95 and a 1 year high of $46.60. The firm’s fifty day simple moving average is $19.23 and its 200 day simple moving average is $21.62. The firm has a market capitalization of $271.73 million, a P/E ratio of 10.98 and a beta of 1.35. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 1.36.
Health Insurance Innovations (NASDAQ:HIIQ) last announced its earnings results on Tuesday, November 12th. The financial services provider reported $0.66 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.14 by $0.52. Health Insurance Innovations had a net margin of 3.93% and a return on equity of 29.73%. The business had revenue of $75.27 million for the quarter, compared to analyst estimates of $91.23 million. During the same quarter in the previous year, the firm posted $0.61 earnings per share. Health Insurance Innovations’s revenue was up 5.3% compared to the same quarter last year. Equities research analysts anticipate that Health Insurance Innovations will post 3.52 EPS for the current fiscal year.
HIIQ has been the topic of several analyst reports. Raymond James lowered shares of Health Insurance Innovations from an outperform rating to a market perform rating in a report on Monday, November 18th. Zacks Investment Research lowered shares of Health Insurance Innovations from a hold rating to a sell rating in a report on Wednesday. Lake Street Capital reissued a buy rating and issued a $50.00 price target (up previously from $40.00) on shares of Health Insurance Innovations in a report on Wednesday, November 13th. ValuEngine raised shares of Health Insurance Innovations from a sell rating to a hold rating in a report on Friday, January 3rd. Finally, Cantor Fitzgerald reissued a buy rating and issued a $80.00 price target on shares of Health Insurance Innovations in a report on Friday, December 20th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have given a buy rating to the company’s stock. The company has an average rating of Hold and a consensus price target of $48.43.
In other Health Insurance Innovations news, major shareholder Michael W. Kosloske sold 309,550 shares of the company’s stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $18.33, for a total transaction of $5,674,051.50. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, major shareholder Michael W. Kosloske sold 52,829 shares of the company’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $18.37, for a total transaction of $970,468.73. The disclosure for this sale can be found here. In the last quarter, insiders have sold 368,629 shares of company stock worth $6,764,145. 47.88% of the stock is owned by corporate insiders.
Health Insurance Innovations Company Profile
Health Insurance Innovations, Inc operates as a cloud-based technology platform and distributor of individual and family health insurance plans, and supplemental products in the United States. It offers short-term medical plans that provide 3 months to 12 months of health insurance coverage with various deductible and copay levels; health benefit insurance plans, which offer fixed cash benefits and additional benefits for procedures and services; and supplemental insurance products, including life insurance policies, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and pharmacy benefit cards.
Read More: What is a Derivative?
Receive News & Ratings for Health Insurance Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations and related companies with MarketBeat.com's FREE daily email newsletter.